Scholarlink

Purpose <p>This study aimed to provide an economic analysis of the Local Health Authority Turin 5 (ASL TO 5) teleophthalmology diabetic retinopathy screening program.</p> Methods <p>A retrospective chart analysis was performed on the diabetologists’ digital folder to compare the costs of ASL TO5 screening program to the Italian standard of care based on in-office examination by ophthalmologist . The total cost was calculated for the two methods of screening. Mean annual unadjusted cost data per patient have been calculated by type of cost component.</p> Results <p>The study included 3,635 patients with diabetes mellitus screened for diabetic retinopathy (DR) in 2023-24. The total (direct and indirect) cost for teleophthalmology screening program was € 48,976 while the estimated cost for the same quantity of patients screened with traditional examination by ophthalmologist would have been € 148,486. The mean cost per patient of telescreening was € 13.5 ± 5.3 . Conversely traditional screening would have a mean cost € 40.9 ± 28 per patient (p-value &lt; 0.001).</p> Discussion <p>Advances in telemedicine are enhancing the DR screening strategies. Telescreening showed cost-savings of approximately € 100,000 for the Local Health Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation Authority ASL TO5 over a period of 2 years and for a screened population of 3,635. Telemedicine-based screening emerges as a less costly solution for the Italian National Health Service and can improve accessibility and compliance to this procedure.</p> Conclusions <p>This study provides an economic analysis of teleophthalmology DR screening program and highlights significant implications for patients, healthcare professionals and policymakers.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diabetic retinopathy screening telemedicine-based compared with standard of care : an economic analysis in a pilot experience of Italian healthcare

  • 期刊论文

  • 发表日期：

    2025年11月3日

查看全文
  • Alberto Piatti,
  • R. Borghese,
  • G. Perino,
  • S. Bellelli,
  • C. Rivoiro,
  • F. Tassone,
  • F. Romeo,
  • M. Doglio,
  • G. Messori Ioli,
  • G. B. Giorda

摘要

Purpose

This study aimed to provide an economic analysis of the Local Health Authority Turin 5 (ASL TO 5) teleophthalmology diabetic retinopathy screening program.

Methods

A retrospective chart analysis was performed on the diabetologists’ digital folder to compare the costs of ASL TO5 screening program to the Italian standard of care based on in-office examination by ophthalmologist . The total cost was calculated for the two methods of screening. Mean annual unadjusted cost data per patient have been calculated by type of cost component.

Results

The study included 3,635 patients with diabetes mellitus screened for diabetic retinopathy (DR) in 2023-24. The total (direct and indirect) cost for teleophthalmology screening program was € 48,976 while the estimated cost for the same quantity of patients screened with traditional examination by ophthalmologist would have been € 148,486. The mean cost per patient of telescreening was € 13.5 ± 5.3 . Conversely traditional screening would have a mean cost € 40.9 ± 28 per patient (p-value < 0.001).

Discussion

Advances in telemedicine are enhancing the DR screening strategies. Telescreening showed cost-savings of approximately € 100,000 for the Local Health Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation Authority ASL TO5 over a period of 2 years and for a screened population of 3,635. Telemedicine-based screening emerges as a less costly solution for the Italian National Health Service and can improve accessibility and compliance to this procedure.

Conclusions

This study provides an economic analysis of teleophthalmology DR screening program and highlights significant implications for patients, healthcare professionals and policymakers.